• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国帕金森病的患病率和发病率:系统评价和荟萃分析。

The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis.

机构信息

Department of Intensive Care Unit, First Affiliated Hospital, Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530023, Guangxi, China.

出版信息

J Neural Transm (Vienna). 2014 Feb;121(2):123-34. doi: 10.1007/s00702-013-1092-z. Epub 2013 Sep 22.

DOI:10.1007/s00702-013-1092-z
PMID:24057652
Abstract

Parkinson's disease (PD) is a chronic neurodegenerative disorder affecting older individuals. There is inconsistent evidence about the prevalence and incidence of PD in China at present. The aim of the meta-analysis was to estimate the prevalence and incidence of PD and its relation to age, gender, and stage in China. The literature search was conducted using PubMed, EMBASE, Chinese Biological Medical Literature database (CBM), Chinese National Knowledge Infrastructure database (CNKI), Chinese Wanfang and Chongqing VIP database for studies investigating the prevalence and incidence of PD in China from the commencement of the database until August 2012; both English and Chinese publications were included. We estimated the prevalence and incidence of PD using meta-analysis. Thirteen eligible articles were collected. The results showed that the pooled prevalence and incidence of PD were 2 per 100,000 population and 797 per 100,000 person-years. A higher prevalence of PD was found in males than in females (OR 1.29, 95 % CI 1.05-1.57). The prevalence of PD increased with age: the highest was 1,663 per 100,000 in those aged 80 and older. The overall prevalence of PD is lower in China than in developed countries, but the incidence is higher than in some developed countries. Overall, the prevalence of PD appears to increase with age and there are sex differences evident in Chinese individuals.

摘要

帕金森病(PD)是一种影响老年人的慢性神经退行性疾病。目前,中国 PD 的患病率和发病率的证据不一致。本荟萃分析的目的是评估 PD 的患病率和发病率及其与年龄、性别和分期在中国的关系。使用 PubMed、EMBASE、中国生物医学文献数据库(CBM)、中国知网(CNKI)、中国万方和重庆维普数据库对中国 PD 的患病率和发病率进行了文献检索,检索时间为数据库建立至 2012 年 8 月;包括英文和中文出版物。我们使用荟萃分析来估计 PD 的患病率和发病率。共收集了 13 篇合格的文章。结果表明,PD 的总体患病率和发病率分别为 2/100,000 人口和 797/100,000 人年。男性 PD 的患病率高于女性(OR 1.29,95%CI 1.05-1.57)。PD 的患病率随年龄增长而增加:80 岁及以上人群患病率最高,为 1663/100,000。中国 PD 的总体患病率低于发达国家,但发病率高于一些发达国家。总体而言,PD 的患病率似乎随年龄增长而增加,中国人群存在性别差异。

相似文献

1
The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis.中国帕金森病的患病率和发病率:系统评价和荟萃分析。
J Neural Transm (Vienna). 2014 Feb;121(2):123-34. doi: 10.1007/s00702-013-1092-z. Epub 2013 Sep 22.
2
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.来自法国E3N队列研究的女性中β-肾上腺素能受体药物的使用与帕金森病发病率
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.
3
National and subnational prevalence and burden of glaucoma in China: A systematic analysis.中国青光眼的全国及地区患病率和疾病负担:一项系统分析。
J Glob Health. 2017 Dec;7(2):020705. doi: 10.7189/jogh.07.020705.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
The national and subnational prevalence of cataract and cataract blindness in China: a systematic review and meta-analysis.中国白内障和盲性白内障的全国和省级流行情况:系统评价和荟萃分析。
J Glob Health. 2018 Jun;8(1):010804. doi: 10.7189/jogh.08.010804.
6
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
7
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
8
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
9
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
10
Chinese herbal medicine for treating recurrent urinary tract infections in women.用于治疗女性复发性尿路感染的中草药
Cochrane Database Syst Rev. 2015 Jun 4;2015(6):CD010446. doi: 10.1002/14651858.CD010446.pub2.

引用本文的文献

1
A systematic review of the efficacy of repetitive transcranial magnetic stimulation in treating dysarthria in patients with Parkinson's disease.重复经颅磁刺激治疗帕金森病患者构音障碍疗效的系统评价
Front Aging Neurosci. 2025 Feb 5;17:1501640. doi: 10.3389/fnagi.2025.1501640. eCollection 2025.
2
Glymphatic system dysfunction as a biomarker of disease progression in Parkinson's disease: neuroimaging evidence from longitudinal cohort studies.类淋巴系统功能障碍作为帕金森病疾病进展的生物标志物:来自纵向队列研究的神经影像学证据
J Neurol. 2025 Feb 11;272(3):196. doi: 10.1007/s00415-025-12944-1.
3
Sex differences in the association between Body Mass Index and cognitive function in Parkinson disease: a cross-sectional study.

本文引用的文献

1
A systematic review of the worldwide prevalence and incidence of Parkinson's disease.帕金森病全球患病率及发病率的系统评价
J Med Assoc Thai. 2011 Jun;94(6):749-55.
2
[A cross-sectional study of neurological disease in the veterans of military communities in Beijing].[北京军队社区退伍军人神经系统疾病的横断面研究]
Zhonghua Nei Ke Za Zhi. 2010 Jun;49(6):463-8.
3
Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan.城乡帕金森病患病率的差异:台湾一项基于人群的研究。
帕金森病中体重指数与认知功能关联的性别差异:一项横断面研究。
Front Nutr. 2024 Jul 5;11:1420225. doi: 10.3389/fnut.2024.1420225. eCollection 2024.
4
Motor dysfunction in Parkinson's patients: depression differences in a latent growth model.帕金森病患者的运动功能障碍:潜在增长模型中的抑郁差异
Front Aging Neurosci. 2024 Jun 3;16:1393887. doi: 10.3389/fnagi.2024.1393887. eCollection 2024.
5
The Role of Diet in Parkinson's Disease.饮食在帕金森病中的作用。
J Parkinsons Dis. 2024;14(s1):S21-S34. doi: 10.3233/JPD-230264.
6
Movement disorders in Indochina: Resource challenges and future solutions.东南亚地区的运动障碍疾病:资源挑战与未来解决方案。
J Neural Transm (Vienna). 2023 Jul;130(7):875-889. doi: 10.1007/s00702-023-02662-1. Epub 2023 Jun 12.
7
Gender Differences in the Prevalence of Parkinson's Disease.帕金森病患病率的性别差异
Mov Disord Clin Pract. 2022 Nov 14;10(1):86-93. doi: 10.1002/mdc3.13584. eCollection 2023 Jan.
8
Editorial: Genetic and molecular diversity in Parkinson's disease.社论:帕金森病的遗传和分子多样性
Front Aging Neurosci. 2022 Dec 16;14:1094914. doi: 10.3389/fnagi.2022.1094914. eCollection 2022.
9
Unraveling Parkinson's Disease Neurodegeneration: Does Aging Hold the Clues?揭开帕金森病神经退行性变的奥秘:衰老是否藏着线索?
J Parkinsons Dis. 2022;12(8):2321-2338. doi: 10.3233/JPD-223363.
10
Effects of remote ischemic conditioning on sleep complaints in Parkinson's disease-rationale, design, and protocol for a randomized controlled study.远程缺血预处理对帕金森病睡眠障碍的影响——一项随机对照研究的理论基础、设计与方案
Front Neurol. 2022 Jul 25;13:932199. doi: 10.3389/fneur.2022.932199. eCollection 2022.
Neuroepidemiology. 2009;33(4):350-7. doi: 10.1159/000254572. Epub 2009 Nov 4.
4
Costs of Parkinson's disease in eastern Europe: a Czech cohort study.东欧帕金森病的成本:捷克队列研究。
Parkinsonism Relat Disord. 2010 Jan;16(1):51-6. doi: 10.1016/j.parkreldis.2009.07.005. Epub 2009 Aug 8.
5
Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California.帕金森病与加利福尼亚中央山谷农业应用中接触代森锰锌和百草枯的居住暴露情况。
Am J Epidemiol. 2009 Apr 15;169(8):919-26. doi: 10.1093/aje/kwp006. Epub 2009 Mar 6.
6
Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century.日本25年间帕金森病患病率和发病率的变化。
Neuroepidemiology. 2009;32(4):263-9. doi: 10.1159/000201565. Epub 2009 Feb 11.
7
Incidence and remaining lifetime risk of Parkinson disease in advanced age.高龄人群中帕金森病的发病率及终生患病风险
Neurology. 2009 Feb 3;72(5):432-8. doi: 10.1212/01.wnl.0000341769.50075.bb.
8
Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction.帕金森病:年龄作为线粒体功能障碍风险因素的首要地位。
Metabolism. 2008 Oct;57 Suppl 2:S50-5. doi: 10.1016/j.metabol.2008.07.015.
9
Caregiver strain in Parkinson's disease and the impact of disease duration.帕金森病中的照料者负担及病程的影响。
Eur J Phys Rehabil Med. 2008 Mar;44(1):39-45.
10
Exploring gene-environment interactions in Parkinson's disease.探索帕金森病中的基因-环境相互作用。
Hum Genet. 2008 Apr;123(3):257-65. doi: 10.1007/s00439-008-0466-z. Epub 2008 Jan 22.